Keywords: GlaxoSmithKline, Dr Reddy's, US penicillin facility, Augmentin, Amoxil, Paxil, Law suit

GlaxoSmithKline sells US penicillin facility and products to India’s Dr Reddy’s; GSK favored in Paxil trial

Article | 24 November 2010

Print This

UK pharmaceutical giant GlaxoSmithKline (LSE: GSK) and Dr Reddy’s Laboratories (NYSE: RDY) have signed an agreement relating to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in